Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
PLoS One ; 12(10): e0185318, 2017.
Article in English | MEDLINE | ID: mdl-28985222

ABSTRACT

The aim was to assess the trace element contents in toenails of older adults and its association with regular physical activity. Cross-sectional multicentre study in Spain, collecting data from a random sample of 380 participants (54% female) aged 55-80 years (men) and 60-80 years (women) with no previously documented cardiovascular disease. Physical activity performed was measured using the Minnesota Leisure-time Physical Activity Questionnaire. The 25 most inactive and 25 most active individuals for each sex were selected for this study (final sample n = 100). Anthropometric measurements were performed and toenail samples collected for calcium (Ca), chromium (Cr), iron (Fe), cobalt (Co), nickel (Ni), zinc (Zn), selenium (Se) and mercury (Hg) analysis. Significant differences between sexes were reported in Ca concentrations, women having lower concentrations than men. No differences were reported in trace element contents between active and inactive men. Active women showed higher Ca, Cr, Fe, Co, and Zn and lower Hg contents than their inactive peers (all p<0.05). Inactive women showed lower Ca and Co levels (735.0 mg/kg and 4.5 µg/kg, respectively) than inactive men (1170.0 mg/kg and 7.9 µg/kg, respectively). Active women had lower Ca and higher levels of Cr (936.0 mg/kg and 1230.0 µg/kg, respectively) than active men (1070.0 mg/kg and 522.0 µg/kg, respectively). The present data added new information on the element contents in toenails of healthy Spanish older adults. The concentration of trace elements was similar in both sexes except for Ca which were lower in women. The trace element contents in women's toenails, but not in men, were markedly influenced by physical activity, with higher levels of Ca and Fe and lower Hg among active females.


Subject(s)
Exercise/physiology , Nails/chemistry , Trace Elements/analysis , Aged , Aged, 80 and over , Calcium/analysis , Chromium/analysis , Cobalt/analysis , Cross-Sectional Studies , Female , Humans , Iron/analysis , Male , Mercury/analysis , Middle Aged , Nickel/analysis , Selenium/analysis , Sex Factors , Spain , Zinc/analysis
2.
Nutr Metab Cardiovasc Dis ; 27(5): 447-455, 2017 May.
Article in English | MEDLINE | ID: mdl-28416098

ABSTRACT

BACKGROUND AND AIMS: Inflammation plays a key role in atherosclerosis and this process seems to appear in childhood. The ideal cardiovascular health index (ICHI) has been inversely related to atherosclerotic plaque in adults. However, evidence regarding inflammation and ICHI in adolescents is scarce. The aim is to assess the association between ICHI and inflammation in European adolescents. METHODS AND RESULTS: As many as 543 adolescents (251 boys and 292 girls) from the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) study, a cross-sectional multi-center study including 9 European countries, were measured. C-reactive protein (CRP), complement factors C3 and C4, leptin and white blood cell counts were used to compute an inflammatory score. Multilevel linear models and multilevel logistic regression were used to assess the association between ICHI and inflammation controlling by covariates. Higher ICHI was associated with a lower inflammatory score, as well as with several individual components, both in boys and girls (p < 0.01). In addition, adolescents with at least 4 ideal components of the ICHI had significantly lower inflammatory score and lower levels of the study biomarkers, except CRP. Finally, the multilevel logistic regression showed that for every unit increase in the ICHI, the probability of having an inflammatory profile decreased by 28.1% in girls. CONCLUSION: Results from this study suggest that a better ICHI is associated with a lower inflammatory profile already in adolescence. Improving these health behaviors, and health factors included in the ICHI, could play an important role in CVD prevention.


Subject(s)
Cardiovascular Diseases/prevention & control , Health Status , Inflammation/prevention & control , Adolescent , Age Factors , Biomarkers/blood , C-Reactive Protein/analysis , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/epidemiology , Chi-Square Distribution , Complement C3/analysis , Complement C4/analysis , Cross-Sectional Studies , Diet/adverse effects , Europe , Female , Humans , Inflammation/diagnosis , Inflammation/epidemiology , Inflammation Mediators/blood , Leptin/blood , Leukocyte Count , Life Style , Linear Models , Logistic Models , Male , Multivariate Analysis , Nutrition Surveys , Odds Ratio , Risk Assessment , Risk Factors , Risk Reduction Behavior
3.
Clin. transl. oncol. (Print) ; 17(11): 884-887, nov. 2015. graf
Article in English | IBECS | ID: ibc-143459

ABSTRACT

Introduction. Autologous tumor cell vaccines rely on the concept of preserving an individual’s own tumorigenic makeup, expressing its unique set of tumor-associated antigens as well as antigenic elements from the surrounding stroma. These autologous tumor characteristics are usually presented with an immune adjuvant in the hopes of enhancing an immune response. Methods. The autologous vaccine we used was composed of tumor cells combined with BCG and formalin. Animal safety and toxicity were evaluated using mice tumors for the immunotherapy. A small number of patients with advanced stage breast cancer were recruited for an uncontrolled study, using the vaccine solely or combined with chemotherapy/radiotherapy. Results. The immunotherapy had shown to be safe in mice and humans. Upon a 5-year follow-up, the survival rate was 60 % for the combined treatment. Conclusions. The data suggest that the combined treatment could be a feasible and safe therapeutic strategy. However, further controlled studies should be conducted (AU)


No disponible


Subject(s)
Adult , Animals , Female , Humans , Mice , Autoantigens , Immunotherapy/instrumentation , Immunotherapy/trends , Immunotherapy , Mycobacterium bovis/isolation & purification , BCG Vaccine/immunology , BCG Vaccine/therapeutic use , Breast Neoplasms/diagnosis , Breast Neoplasms/immunology , Immunotherapy/methods , Immunotherapy/standards , Breast Neoplasms/drug therapy , Breast Neoplasms/radiotherapy , Chemotherapy, Adjuvant/methods , Chemotherapy, Adjuvant/veterinary , Radiotherapy, Adjuvant/methods , Radiotherapy, Adjuvant/veterinary , Chemoradiotherapy, Adjuvant/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...